# Ernexa Therapeutics Inc.: Form SC 13D, filed Dec 20, 2022

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D
- Filed: 2022-12-20
- Accepted by EDGAR: Dec 20, 2022, 16:30 ET
- Period: not reported
- Accession: 0001140361-22-046379
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036122046379/brhc10045710_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036122046379/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036122046379/brhc10045710_sc13d.htm

Filed Dec 20, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-046379. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
